MVA-SARS-2-S

MVA-SARS-2-S Uses, Dosage, Side Effects, Food Interaction and all others data.

MVA-SARS-2-S is a COVID-19 vaccine candidate that contains a Modified Vaccinia Virus Ankara (MVA) vector expressing the SARS-CoV-2 spike protein. MVA is a highly attenuated poxvirus vector that has a high-level of biological safety due to its quality of being a non-replicating virus in mammalian hosts and is used to develop vaccines for infectious diseases and cancer.

Trade Name MVA-SARS-2-S
Generic MVA-SARS-2-S
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
MVA-SARS-2-S
MVA-SARS-2-S

Innovators Monograph

You find simplified version here MVA-SARS-2-S


*** Taking medicines without doctor's advice can cause long-term problems.
Share